BIOCRYST PHARMACEUTICALS INC (BCRX) › RevenueBIOCRYST PHARMACEUTICALS INC (BCRX) — RevenueAnnual figures by fiscal year, from SEC filings.2016: $26.35M2017: $25.19M2018: $20.65M2019: $48.84M2020: $17.81M2021: $157.17M2022: $270.83M2023: $331.41M2024: $450.71M2025: $874.84M$874.84M2016Revenue (USD)2025Fiscal YearRevenueChange YoY2025$874.84M+94.1%2024$450.71M+36.0%2023$331.41M+22.4%2022$270.83M+72.3%2021$157.17M+782.4%2020$17.81M-63.5%2019$48.84M+136.5%2018$20.65M-18.0%2017$25.19M-4.4%2016$26.35M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share